
bespark*bio is a biotech company focused on advanced process development for novel biotherapeutics, including vaccines, immuno-oncology, and cell & gene therapy. Their approach integrates bioprocessing expertise, state-of-the-art technology, digitalization, and machine learning to optimize bioproduction from lab to clinic. They offer services such as CMC strategy development, process design and optimization, analytical development, and GMP support. bespark*bio aims to reduce cost, time, and risk for their clients, enabling faster and more efficient development of biotherapeutics. The company has been recognized with the Mercur Innovation Award for its Gene Therapy Technology and the Univie Entrepreneurship Award.

bespark*bio is a biotech company focused on advanced process development for novel biotherapeutics, including vaccines, immuno-oncology, and cell & gene therapy. Their approach integrates bioprocessing expertise, state-of-the-art technology, digitalization, and machine learning to optimize bioproduction from lab to clinic. They offer services such as CMC strategy development, process design and optimization, analytical development, and GMP support. bespark*bio aims to reduce cost, time, and risk for their clients, enabling faster and more efficient development of biotherapeutics. The company has been recognized with the Mercur Innovation Award for its Gene Therapy Technology and the Univie Entrepreneurship Award.